3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
11
Squamous Cell Carcinoma of Head and Neck
8
Oropharyngeal Neoplasms
7
Cholangiocarcinoma
7
Pancreatic Neoplasms
6
Lung Neoplasms
6
Urinary Bladder Neoplasms
5
Ovarian Neoplasms
4
Mouth Neoplasms
4
Laryngeal Neoplasms
4
Gallbladder Neoplasms
4
Carcinoma
4
Sarcoma
3
Hypopharyngeal Neoplasms
3
Fallopian Tube Neoplasms
3
Urethral Neoplasms
2
Stomach Neoplasms
2
Peritoneal Neoplasms
2
Paranasal Sinus Neoplasms
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Mesothelioma, Malignant
2
Klatskin Tumor
2
Colorectal Neoplasms
2
Vulvar Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Ureteral Neoplasms
1
Testicular Neoplasms
1
Stomatitis
1
Interventions
Oxaliplatin
112
Fluorouracil
104
Leucovorin
91
Irinotecan
91
Capecitabine
59
Bevacizumab
58
Cetuximab
46
Folfox protocol
28
Colonoscopy
24
Panitumumab
19
Chemotherapy, Adjuvant
19
Blood Specimen Collection
19
Drug Therapy
18
Nivolumab
17
Magnetic Resonance Spectroscopy
17
Radiotherapy
16
Exercise
16
Early Intervention, Educational
16
Surveys and Questionnaires
15
Laparoscopy
15
Surgical Procedures, Operative
13
Floxuridine
13
Biopsy
13
trifluridine tipiracil drug combination
12
pembrolizumab
12
XELOX
12
Neoadjuvant Therapy
11
Methods
11
Immunohistochemistry
11
Celecoxib
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Colonic Neoplasms
×
1,2-diaminocyclohexaneplatinum II citrate
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled